Roger L Headrick
Insider
First SEC filing: May 24, 2007 · Latest: May 24, 2007
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2007 | CVS | P | 113 | $38.04 | $4,299 | 2,200 Indirect | +5.41% | Acquired | 127.2% (price as of 2026-10-06) |
| May 23, 2007 | CVS | P | 3,000 | $38.03 | $114,090 | 324,262 Direct | +0.93% | Acquired | 127.3% (price as of 2026-10-06) |
| May 23, 2007 | CVS | P | 2,500 | $38.00 | $95,000 | 321,262 Direct | +0.78% | Acquired | 127.4% (price as of 2026-10-06) |
| May 23, 2007 | CVS | P | 882 | $37.99 | $33,507 | 318,762 Direct | +0.28% | Acquired | 127.5% (price as of 2026-10-06) |
| May 9, 2007 | CVS | A | 7,980 | $38.02 | $303,400 | 317,880 Direct | +2.58% | Acquired | 127.3% (price as of 2026-10-06) |
| May 8, 2007 | CVS | A | 27 | $37.01 | $999 | 309,900 Direct | +0.01% | Acquired | 133.5% (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 33,726 | · | · | 33,726 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 33,739 | · | · | 33,739 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,856 | · | · | 46,856 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,844 | · | · | 46,844 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,851 | · | · | 46,851 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,849 | · | · | 46,849 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 2,087 | $34.80 | $72,628 | 2,087 Indirect | · | Acquired | 148.4% (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 29,313 | $34.80 | $1,020,092 | 309,873 Direct | +10.45% | Acquired | 148.4% (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 280,560 | $34.80 | $9,763,488 | 280,560 Direct | · | Acquired | 148.4% (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 33,726 | · | · | 33,726 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 33,739 | · | · | 33,739 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,844 | · | · | 46,844 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 46,851 | · | · | 46,851 Direct | · | Acquired | (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 29,313 | $34.80 | $1,020,092 | 311,961 Direct | +10.37% | Acquired | 148.4% (price as of 2026-10-06) |
| March 22, 2007 | CVS | A | 282,648 | $34.80 | $9,836,150 | 282,648 Direct | · | Acquired | 148.4% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 22, 2007 | CVS | Stock Option | Common Stock | $27.12 | March 1, 2016 | 33,726 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $20.23 | March 1, 2015 | 33,739 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $13.41 | Jan. 2, 2014 | 46,856 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $8.42 | Jan. 2, 2012 | 46,844 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $6.53 | Jan. 12, 2011 | 46,851 | Acquired |
| March 22, 2007 | CVS | Share Credits | Common Stock | $9.17 | Feb. 25, 2013 | 46,849 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $27.12 | March 1, 2016 | 33,726 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $20.23 | March 1, 2015 | 33,739 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $8.42 | Jan. 2, 2012 | 46,844 | Acquired |
| March 22, 2007 | CVS | Stock Option | Common Stock | $6.53 | Jan. 12, 2011 | 46,851 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).